# Moyamoya syndrome in a 6-year-old β-thalassemia major patient: A case report

**Authors:** Maryam Shaukat, Muhammad Aman, Hania Fatima, Faheemullah Khan, Naila Nadeem, Sadaf Altaf, Khabab Abbasher Hussien Mohamed Ahmed

PMC · DOI: 10.1016/j.radcr.2025.04.129 · Radiology Case Reports · 2025-05-29

## TL;DR

A 6-year-old girl with β-thalassemia major developed moyamoya syndrome, a rare cerebrovascular condition, highlighting the need for early detection and treatment.

## Contribution

This case report adds to the limited literature on the rare co-occurrence of moyamoya syndrome and β-thalassemia major.

## Key findings

- The patient exhibited left-sided hemiparesis and radiological features consistent with moyamoya syndrome.
- Diagnostic imaging confirmed the presence of moyamoya syndrome in a β-thalassemia major patient.
- The case emphasizes the importance of early recognition to prevent neurological complications.

## Abstract

Moyamoya disease (MMD) is a rare, chronic cerebrovascular disorder involving progressive bilateral stenosis of the internal carotid artery and its branches, forming abnormal collateral networks that appear as a “puff of smoke” on angiography. While the term MMD is used when the condition is idiopathic, it is called moyamoya syndrome (MMS) when associated with underlying systemic conditions. Reports of MMS with β-thalassemia major are rare, with fewer than 6 cases documented; herein, we report a case of a 6-year-old female, a known case of β-thalassemia major, who exhibited left-sided hemiparesis, revealing radiological and clinical features consistent with MMS. MRI, CTA, EEG, and Echocardiography were used as diagnostic workups to confirm the diagnosis. The patient was treated with hyper-transfusion therapy and pharmacological management, with an ongoing consideration of surgical intervention. The rarity of the occurrence of moyamoya syndrome in β-thalassemia major patients has been discussed, with emphasis on the importance of early recognition and intervention to mitigate neurological complications. This case contributes to the limited literature on β-thalassemia major and MMS occurring together, underscoring the need for heightened clinical awareness and timely management strategies.

## Full-text entities

- **Diseases:** MMD (MESH:D009072), β-thalassemia major (MESH:D017086), cerebrovascular disorder (MESH:D002561), neurological complications (MESH:D002493), hemiparesis (MESH:D010291), stenosis (MESH:D003251)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12159822/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12159822/full.md

## References

31 references — full list in the complete paper: https://tomesphere.com/paper/PMC12159822/full.md

---
Source: https://tomesphere.com/paper/PMC12159822